Evidence map›Paper›PMID 37873488›Full record

ArticlebioRxiv : the preprint server for biology2023

Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development.

Marc D Ryser, Matthew A Greenwald, Inmaculada C Sorribes, Lorraine M King, Allison Hall, Joseph Geradts, Donald L Weaver, Diego Mallo, Shannon Holloway, Daniel Monyak and 9 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Marc D RyserDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Matthew A GreenwaldDepartment of Biology, Duke University, Durham, NC, USA.
Inmaculada C SorribesDepartment of Mathematics, Duke University, Durham, NC, USA.
Lorraine M KingDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA.
Allison HallDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Joseph GeradtsDepartment of Pathology, East Carolina University School of Medicine, Greenville, NC, USA.
Donald L WeaverLarner College of Medicine, University of Vermont and UVM Cancer Center, Burlington, VT, USA.
Diego MalloArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.
Shannon HollowayDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Daniel MonyakTrinity College of Arts and Sciences, Duke University, Durham, NC.
Graham GumbertTrinity College of Arts and Sciences, Duke University, Durham, NC.
Shariar Vaez-GhaemiTrinity College of Arts and Sciences, Duke University, Durham, NC.
Ethan WuTrinity College of Arts and Sciences, Duke University, Durham, NC.
Kevin MurgasDepartment of Biomedical Informatics, Stony Brook University School of Medicine, Stony Brook, NY, USA.
Lars J GrimmDepartment of Radiology, Duke University School of Medicine, Durham, NC, USA.
Carlo C MaleyArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.
Jeffrey R MarksDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA.
Darryl ShibataDepartment of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
E Shelley HwangDepartment of Surgery, Duke University School of Medicine, Durham, NC, USA.
Duke University · USBiocom · USEast Carolina University · USStony Brook University · USUniversity of Southern California · USUniversity of Vermont · US

Funding

PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233254 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY · 2018 to 2023
$11.4M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
Breast Cancer Detection ConsortiumU01CA214183 · NCI · DUKE UNIVERSITY · PI MARKS, JEFFREY R., TANG, CHA-MEI · 2016 to 2021
$2.4M
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCISR01CA185138 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY, MALEY, CARLO · 2014 to 2017
$2.0M
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer RiskR00CA207872 · NCI · DUKE UNIVERSITY · PI RYSER, MARC · 2018 to 2020
$746k
The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer RiskK99CA207872 · NCI · DUKE UNIVERSITY · PI RYSER, MARC · 2016 to 2017
$318k
NCI NIH HHS K99 CA207872NCI NIH HHS P01 CA091955NCI NIH HHS R00 CA207872NCI NIH HHS R01 CA140657NCI NIH HHS R01 CA185138NCI NIH HHS U01 CA214183NCI NIH HHS U2C CA233254NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

Ductal carcinoma in situ (DCIS) and invasive breast cancer share many morphologic, proteomic, and genomic alterations. Yet in contrast to invasive cancer, many DCIS tumors do not progress and may remain indolent over decades. To better understand the heterogenous nature of this disease, we reconstructed the growth dynamics of 18 DCIS tumors based on the geo-spatial distribution of their somatic mutations. The somatic mutation topographies revealed that DCIS is multiclonal and consists of spatially discontinuous subclonal lesions. Here we show that this pattern of spread is consistent with a new 'Comet' model of DCIS tumorigenesis, whereby multiple subclones arise early and nucleate the buds of the growing tumor. The discontinuous, multiclonal growth of the Comet model is analogous to the branching morphogenesis of normal breast development that governs the rapid expansion of the mammary epithelium during puberty. The branching morphogenesis-like dynamics of the proposed Comet model diverges from the canonical model of clonal evolution, and better explains observed genomic spatial data. Importantly, the Comet model allows for the clinically relevant scenario of extensive DCIS spread, without being subjected to the selective pressures of subclone competition that promote the emergence of increasingly invasive phenotypes. As such, the normal cell movement inferred during DCIS growth provides a new explanation for the limited risk of progression in DCIS and adds biologic rationale for ongoing clinical efforts to reduce DCIS overtreatment.

Identifiers

PMID37873488
PMCPMC10592867
OpenAlexW4387244152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.